GO:0003417 growth plate cartilage development: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003417 growth plate cartilage development describes the progression of cartilage that provides a scaffold for mineralization of endochondral bones as they elongate or grow.
• The growth plate is a highly organized cartilage structure where chondrocytes proliferate, mature, and undergo hypertrophy before being replaced by bone.
• SOX9 is a master transcription factor that keeps growth plate and articular cartilage healthy by inhibiting chondrocyte dedifferentiation and osteoblastic redifferentiation.
• Multiple signaling pathways, including FGF, BMP, IHH, and Wnt, regulate growth plate formation and activity.
• Dysregulation of growth plate cartilage development leads to skeletal disorders such as achondroplasia, chondrodysplasias, and other growth defects.
• CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, are essential for dissecting gene function in growth plate cartilage development.
Description
GO:0003417 growth plate cartilage development is a biological process that encompasses the progression of the cartilage that will provide a scaffold for mineralization of endochondral bones as they elongate or grow. This process is fundamental to skeletal development and linear growth in vertebrates. The growth plate, also known as the epiphyseal plate, is a specialized cartilaginous structure located near the ends of long bones, where chondrocytes undergo a tightly regulated program of proliferation, differentiation, and hypertrophy. Disruption of this process results in a wide range of skeletal dysplasias and growth disorders. Understanding the molecular and cellular mechanisms of growth plate cartilage development is therefore critical for both developmental biology and clinical genetics. Recent studies have identified key transcription factors, signaling pathways, and extracellular matrix components that orchestrate this process. For researchers, GO:0003417 provides a framework to study how cartilage serves as a template for bone formation and how genetic mutations perturb skeletal growth.
growth plate cartilage development At A Glance
| GO ID | GO:0003417 |
|---|---|
| GO term | growth plate cartilage development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Progression of cartilage that provides a scaffold for mineralization of endochondral bones during elongation or growth |
| Related process | Endochondral ossification, chondrocyte differentiation, skeletal development |
| Key cell types | Chondrocytes (resting, proliferative, prehypertrophic, hypertrophic), osteoblasts, osteoclasts, skeletal stem cells |
| Key signaling pathways | FGF, BMP, IHH, Wnt, Notch |
| Associated diseases | Achondroplasia, chondrodysplasias, growth plate abnormalities |
What Is GO:0003417?
According to the Gene Ontology, GO:0003417 growth plate cartilage development is defined as the process whose specific outcome is the progression of the cartilage that will provide a scaffold for mineralization of endochondral bones as they elongate or grow. In simpler terms, it is the series of biological events by which the growth plate cartilage forms, matures, and organizes itself to support the replacement of cartilage by bone during skeletal growth.
Why Is growth plate cartilage development Important in Cell Biology?
Growth plate cartilage development is essential for normal skeletal growth and stature, as it directly determines the rate and extent of long bone elongation. Defects in this process cause a spectrum of skeletal disorders, including achondroplasia, thanatophoric dysplasia, and multiple epiphyseal dysplasias, which affect millions of individuals worldwide. Moreover, understanding the regulatory mechanisms of growth plate cartilage development provides insights into cartilage regeneration, bone repair, and potential therapeutic targets for growth disorders.
• Provides the structural template for endochondral bone formation and linear growth.
• Dysregulation leads to skeletal dysplasias such as achondroplasia and chondrodysplasias.
• SOX9 maintains chondrocyte identity and prevents premature dedifferentiation in the growth plate.
• FGF signaling, including FGF-2 and FGF-18, regulates chondrocyte proliferation and differentiation.
• Perlecan in the extracellular matrix modulates growth factor activity and cartilage homeostasis.
• Skeletal stem cells in the growth plate transition from cartilage to bone and are critical for bone elongation.
• DDRGK1 is required for proper development and maintenance of growth plate cartilage.
• FGF19 disrupts cartilage development via the FGFR4/β-catenin axis, highlighting crosstalk between signaling pathways.
• Animal models and CRISPR screens are essential for identifying novel regulators of growth plate development.
What Happens During growth plate cartilage development?
Chondrocyte proliferation and columnar organization
In simple terms: Cartilage cells multiply and line up in columns, forming the growth plate's proliferative zone.
In the proliferative zone of the growth plate, chondrocytes undergo rapid division and arrange themselves into vertical columns, which is essential for directional bone growth. This process is regulated by a complex interplay of signaling pathways, including FGF and BMP, which control the rate of chondrocyte proliferation and the timing of differentiation. SOX9 is critical for maintaining the proliferative capacity of chondrocytes and preventing their premature dedifferentiation.
Chondrocyte hypertrophy and matrix remodeling
In simple terms: Cartilage cells enlarge and change the surrounding matrix to prepare for bone formation.
As chondrocytes exit the proliferative zone, they undergo hypertrophy, characterized by a significant increase in cell volume and extensive remodeling of the extracellular matrix. Hypertrophic chondrocytes secrete factors such as Indian hedgehog (IHH) and vascular endothelial growth factor (VEGF), which promote vascular invasion and the recruitment of osteoblasts and osteoclasts. This step is tightly regulated by transcription factors including RUNX2 and MEF2C.
Cartilage mineralization and vascular invasion
In simple terms: The cartilage matrix becomes mineralized and blood vessels grow in, bringing bone-forming cells.
The hypertrophic cartilage matrix undergoes mineralization, providing a scaffold for bone deposition. Vascular invasion from the metaphysis brings in osteoprogenitor cells, osteoclasts, and hematopoietic cells, which initiate the replacement of cartilage with bone. This process is dependent on proper signaling through the FGF and Wnt pathways.
Transition from cartilage to bone
In simple terms: The temporary cartilage is gradually replaced by bone tissue.
The final stage of growth plate cartilage development involves the removal of mineralized cartilage by osteoclasts and the deposition of bone matrix by osteoblasts. Skeletal stem cells within the growth plate and adjacent perichondrium contribute to this transition, ensuring coordinated bone elongation. Disruption of this transition leads to growth plate abnormalities and skeletal defects.
Key Genes Involved in GO:0003417 growth plate cartilage development
The following genes and proteins play critical roles in growth plate cartilage development, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOX9 | Master transcription factor maintaining chondrocyte identity and preventing dedifferentiation | Knockout models show severe chondrodysplasia; key target for cartilage regeneration research |
| FGFR3 | Negative regulator of chondrocyte proliferation; mutations cause achondroplasia | Point mutation models mimic human dwarfism; drug screening target |
| FGF18 | Regulates chondrocyte proliferation and differentiation in the growth plate | Overexpression and knockout models reveal roles in cartilage homeostasis |
| FGF2 | Modulates chondrocyte activity and matrix production | Used in cartilage tissue engineering and growth plate studies |
| Perlecan (HSPG2) | Extracellular matrix proteoglycan that regulates growth factor activity | Knockout models show growth plate abnormalities; relevant to Schwartz-Jampel syndrome |
| DDRGK1 | Required for proper development and maintenance of growth plate cartilage | Knockout models exhibit skeletal dysplasia; linked to spondyloepiphyseal dysplasia |
| IHH | Regulates chondrocyte proliferation and hypertrophy; coordinates with PTHrP | Knockout models show shortened bones; target for skeletal repair |
| PTHrP | Maintains proliferative chondrocytes and delays hypertrophy | Overexpression causes delayed ossification; relevant to Jansen metaphyseal chondrodysplasia |
| RUNX2 | Transcription factor essential for osteoblast differentiation and cartilage mineralization | Knockout mice lack bone; key for osteoblast lineage studies |
| MEF2C | Regulates hypertrophic chondrocyte differentiation | Conditional knockout models reveal growth plate defects |
| FGFR4 | Mediates FGF19 signaling to disrupt cartilage development | Overexpression models show cartilage degradation; target for FGF19-related disorders |
| β-catenin | Wnt signaling effector involved in chondrocyte proliferation and differentiation | Knockout and overexpression models show growth plate abnormalities |
| VEGF | Promotes vascular invasion in the growth plate | Inhibition blocks bone formation; used in angiogenesis studies |
| MMP13 | Matrix metalloproteinase that degrades cartilage matrix during hypertrophy | Knockout models show delayed ossification; relevant to arthritis |
| COL2A1 | Major collagen in cartilage matrix; mutations cause chondrodysplasias | Knock-in models of collagenopathies; structural studies |
| COL10A1 | Hypertrophic chondrocyte marker; mutations cause metaphyseal chondrodysplasia | Overexpression and knockout models for growth plate studies |
| Sox5/Sox6 | Co-regulators with SOX9 in chondrogenesis | Triple knockout models show severe cartilage defects |
| FGF19 | Disrupts cartilage development via FGFR4/β-catenin axis | Transgenic models for cartilage degeneration; drug target |
How Is growth plate cartilage development Regulated?
Growth plate cartilage development is regulated by a complex network of signaling pathways and transcription factors. FGF signaling, particularly through FGFR3, acts as a negative regulator of chondrocyte proliferation, while BMP and IHH signaling promote differentiation and hypertrophy. SOX9 is a master regulator that maintains chondrocyte identity and prevents dedifferentiation, and its activity is modulated by post-translational modifications and interacting partners. Perlecan in the extracellular matrix regulates the bioavailability of FGF-2 and FGF-18, thereby influencing growth plate maturation. Additionally, FGF19 has been shown to disrupt cartilage development via the FGFR4/β-catenin axis, highlighting crosstalk between FGF and Wnt pathways. DDRGK1 is also required for proper growth plate maintenance, though its exact regulatory mechanism is still under investigation.
growth plate cartilage development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FGFR3 | Achondroplasia, thanatophoric dysplasia | Point mutation knock-in mice (e.g., Gly380Arg) |
| DDRGK1 | Spondyloepiphyseal dysplasia | Knockout mouse and chondrocyte-specific conditional KO |
| SOX9 | Campomelic dysplasia, osteoarthritis | Conditional knockout and overexpression models |
| COL2A1 | Chondrodysplasias, Stickler syndrome | Knock-in mice with collagen mutations |
| FGF19/FGFR4 | Cartilage degeneration, metabolic bone disease | Transgenic overexpression and knockout models |
Achondroplasia and related skeletal dysplasias
Achondroplasia, the most common form of dwarfism, is caused by activating mutations in FGFR3, which leads to excessive inhibition of chondrocyte proliferation in the growth plate. This results in shortened long bones and characteristic craniofacial features. Other skeletal dysplasias, such as thanatophoric dysplasia and hypochondroplasia, are also linked to FGFR3 mutations. Understanding growth plate cartilage development is essential for developing targeted therapies for these conditions.
DDRGK1-related spondyloepiphyseal dysplasia
Mutations in DDRGK1 cause a rare skeletal disorder characterized by growth plate abnormalities and short stature. Studies in mouse models have shown that DDRGK1 is required for proper development and maintenance of growth plate cartilage, and its loss leads to impaired chondrocyte differentiation and matrix production. This highlights the importance of ER stress and protein modification pathways in growth plate biology.
Osteoarthritis and cartilage degeneration
Although osteoarthritis is primarily a disease of articular cartilage, defects in growth plate cartilage development can predispose to joint abnormalities and early-onset osteoarthritis. SOX9 dysfunction leads to chondrocyte dedifferentiation and loss of cartilage integrity, which is a hallmark of osteoarthritis. FGF19-mediated disruption of cartilage via FGFR4/β-catenin signaling also contributes to cartilage degradation, suggesting potential therapeutic targets.
From growth plate cartilage development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of gene X cause growth plate defects? | Knockout (constitutive or conditional) |
| Does a specific point mutation in FGFR3 mimic achondroplasia? | Point mutation knock-in (e.g., FGFR3 G380R) |
| Can overexpression of FGF19 disrupt cartilage development? | Transgenic overexpression or viral delivery |
| Where is DDRGK1 expressed in the growth plate? | Tagged knock-in (e.g., GFP or HA) |
| What is the role of SOX9 in maintaining chondrocyte identity? | Inducible knockout and lineage tracing |
| How does perlecan regulate FGF signaling? | Knockout and rescue with mutant perlecan |
How to Study the growth plate cartilage development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Histology (Alcian blue, von Kossa) | Cartilage matrix and mineralization | Phenotyping growth plate defects in mouse models |
| Immunofluorescence | Protein localization and expression | Validating knockout and knock-in models |
| RNA-seq | Transcriptome changes | Identifying differentially expressed genes in chondrocytes |
| Single-cell RNA-seq | Cell heterogeneity and lineage trajectories | Discovering skeletal stem cell populations |
| Proteomics | Protein composition of cartilage matrix | Analyzing extracellular matrix remodeling |
| CRISPR knockout screening | Gene essentiality for chondrocyte growth | Identifying novel regulators of growth plate development |
| Western blot | Protein expression and modification | Validating signaling pathway activation |
| Micro-CT | Bone morphology and density | Assessing skeletal phenotypes in mutant mice |
Histology and imaging of growth plates
Histological staining (e.g., Alcian blue, von Kossa) and immunofluorescence are used to visualize growth plate zones and matrix composition. Confocal imaging of fluorescent reporters in transgenic mice allows tracking of chondrocyte proliferation and hypertrophy. These methods are essential for phenotyping knockout and knock-in models.
RNA sequencing and transcriptomics
RNA-seq of microdissected growth plate zones or sorted chondrocytes reveals gene expression changes during differentiation. Single-cell RNA-seq has identified distinct chondrocyte subpopulations and skeletal stem cells in the growth plate. These approaches help identify novel regulators and pathways.
Proteomics and matrix analysis
Mass spectrometry-based proteomics of cartilage matrix can identify compositional changes in growth plate cartilage. Western blotting and immunohistochemistry are used to validate protein expression and post-translational modifications. These methods are crucial for understanding extracellular matrix remodeling.
CRISPR screening and functional genomics
Pooled CRISPR knockout screens in chondrogenic cell lines or primary chondrocytes can identify genes required for proliferation and differentiation. Focused screens targeting signaling pathways (e.g., FGF, BMP) have uncovered new regulators of growth plate development. These functional genomics approaches accelerate target discovery.
How CRISPR Can Be Used to Study GO:0003417 growth plate cartilage development
Knockout
CRISPR knockout is widely used to study loss-of-function of genes in growth plate cartilage development. For example, knockout of SOX9 in chondrocytes leads to severe cartilage defects and dedifferentiation. DDRGK1 knockout mice exhibit growth plate abnormalities, confirming its essential role. These models are generated by introducing frameshift mutations in early exons using Cas9 and guide RNAs.
Point Mutation
Point mutation knock-in models are critical for mimicking human skeletal dysplasias. The FGFR3 G380R mutation, which causes achondroplasia, has been introduced into mice using CRISPR-Cas9 and homology-directed repair. Such models allow precise interrogation of signaling pathways and drug responses.
Knock-in
Knock-in of reporter genes (e.g., GFP, lacZ) or epitope tags (e.g., HA, FLAG) enables visualization and purification of specific cell populations. For instance, knock-in of GFP into the Col10a1 locus marks hypertrophic chondrocytes. This approach is valuable for lineage tracing and cell sorting in growth plate studies.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression is used to study gain-of-function of genes in growth plate cartilage development. Overexpression of FGF19 in cartilage disrupts development via FGFR4/β-catenin signaling. Similarly, overexpression of PTHrP delays chondrocyte hypertrophy and ossification. These models help define dosage-sensitive pathways.
How EDITGENE Supports growth plate cartilage development Research
Researchers studying growth plate cartilage development-related genes often need to determine whether a candidate gene is causally involved in chondrocyte proliferation, differentiation, or matrix remodeling. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for growth plate cartilage development research.
Frequently Asked Questions About growth plate cartilage development
What is GO:0003417 growth plate cartilage development?
GO:0003417 is a Gene Ontology biological process term defined as the progression of the cartilage that will provide a scaffold for mineralization of endochondral bones as they elongate or grow.
What genes are involved in growth plate cartilage development?
Key genes include SOX9, FGFR3, FGF18, FGF2, Perlecan (HSPG2), DDRGK1, IHH, PTHrP, RUNX2, MEF2C, FGFR4, β-catenin, VEGF, MMP13, COL2A1, COL10A1, and FGF19.
How does SOX9 regulate growth plate cartilage development?
SOX9 is a master transcription factor that maintains chondrocyte identity and prevents dedifferentiation and osteoblastic redifferentiation, thereby keeping growth plates healthy.
What signaling pathways control growth plate cartilage development?
FGF, BMP, IHH, Wnt, and Notch pathways are major regulators of chondrocyte proliferation, differentiation, and hypertrophy in the growth plate.
What diseases are associated with defective growth plate cartilage development?
Achondroplasia, thanatophoric dysplasia, spondyloepiphyseal dysplasia, and other chondrodysplasias are linked to defects in growth plate cartilage development.
How is DDRGK1 involved in growth plate cartilage?
DDRGK1 is required for proper development and maintenance of growth plate cartilage; its loss leads to skeletal dysplasia in mice.
What is the role of FGF19 in cartilage development?
FGF19 disrupts cartilage development via the FGFR4/β-catenin axis, leading to impaired chondrocyte function.
How can CRISPR be used to study growth plate cartilage development?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes in chondrocytes and mouse models.
What are the best model systems for growth plate research?
Mouse models (knockout, knock-in, transgenic) and chondrogenic cell lines are widely used, complemented by CRISPR screening and single-cell RNA-seq.
What methods are used to analyze growth plate cartilage development?
Histology, immunofluorescence, RNA-seq, single-cell RNA-seq, proteomics, micro-CT, and CRISPR screens are commonly used.
Conclusion
GO:0003417 growth plate cartilage development is a fundamental biological process that underpins skeletal growth and endochondral bone formation. Decades of research have identified critical genes, signaling pathways, and cellular transitions that regulate this process, and their dysregulation leads to a range of skeletal disorders. Advances in CRISPR-based models and functional genomics are accelerating the discovery of new regulators and potential therapeutic targets. EDITGENE provides comprehensive services to support researchers in dissecting the molecular mechanisms of growth plate cartilage development and translating findings into clinical applications.
References
- 1. Chen H et al.. 2025. Fibroblast Growth Factor 19 Disrupts Cartilage Development Via the FGFR4/β-catenin Axis.. Int J Biol Sci 21(10):4428-4449 PMID: 40765829
- 2. Haseeb A et al.. 2021. SOX9 keeps growth plates and articular cartilage healthy by inhibiting chondrocyte dedifferentiation/osteoblastic redifferentiation.. Proc Natl Acad Sci U S A 118(8) PMID: 33597301
- 3. Hayes AJ et al.. 2022. Regulation of FGF-2, FGF-18 and Transcription Factor Activity by Perlecan in the Maturational Development of Transitional Rudiment and Growth Plate Cartilages and in the Maintenance of Permanent Cartilage Homeostasis.. Int J Mol Sci 23(4) PMID: 35216048
- 4. Matsushita Y et al.. 2020. Growth plate skeletal stem cells and their transition from cartilage to bone.. Bone 136:115359 PMID: 32276155
- 5. Brighton CT. 1984. The growth plate.. Orthop Clin North Am 15(4):571-95 PMID: 6387573
- 6. Michigami T. 2013. Regulatory mechanisms for the development of growth plate cartilage.. Cell Mol Life Sci 70(22):4213-21 PMID: 23640571
- 7. Weisz-Hubshman M et al.. 2022. DDRGK1 is required for the proper development and maintenance of the growth plate cartilage.. Hum Mol Genet 31(16):2820-2830 PMID: 35377455
- 8. Samsa WE et al.. 2017. Signaling pathways regulating cartilage growth plate formation and activity.. Semin Cell Dev Biol 62:3-15 PMID: 27418125
